EPA:ALECR - Euronext Paris - Matif - FR0013256518 - Common Stock - Currency: EUR
EPA:ALECR (8/4/2025, 7:00:00 PM)
17600
-700 (-3.83%)
The current stock price of ALECR.PA is 17600 EUR. In the past month the price decreased by -16.19%. In the past year, price increased by 181.6%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
1TMO.MI | THERMO FISHER SCIENTIFIC INC | 20.39 | 147.75B | ||
TN8.DE | THERMO FISHER SCIENTIFIC INC | 20.79 | 147.49B | ||
DAP.DE | DANAHER CORP | 26.27 | 121.51B | ||
LO3.DE | LONZA GROUP AG-REG | 35.52 | 41.08B | ||
56S1.DE | SARTORIUS STEDIM BIOTECH | 40.51 | 16.28B | ||
DIM.PA | SARTORIUS STEDIM BIOTECH | 40.4 | 16.24B | ||
SRT3.DE | SARTORIUS AG-VORZUG | 41.61 | 13.55B | ||
ILU.DE | ILLUMINA INC | 22.57 | 12.75B | ||
ERF.PA | EUROFINS SCIENTIFIC | 20.14 | 12.11B | ||
ESF0.DE | EUROFINS SCIENTIFIC | 19.75 | 11.87B | ||
SRT.DE | SARTORIUS AG | 34.25 | 11.16B | ||
QIA.DE | QIAGEN N.V. | 20.44 | 8.90B |
Eurofins-Cerep SA engages in the provision of preclinical drug research services. The company is headquartered in Celle-Levescault, Nouvelle-Aquitaine and currently employs 218 full-time employees. The company went IPO on 2010-03-19. The Company, using its BioPrint technology systems that analyzes pharmaceutical drugs on the market, those that have been withdrawn, and those that failed in the development stages, builds up predictive models of the potential of new drugs. These predictions are based on the drugs' chemical structure and their performance in vitro. The firm then offers solutions to the pharmaceutical and biotechnology sectors on reducing time and costs in the early stages of the drug development process. Clients can also gain access to some of the Company's technology by subscribing to BioPrint. The Company’s maximum revenue is generated through Exports accounts.
EUROFINS CEREP-REGR
Le Bois l'Eveque
Celle-Levescault NOUVELLE-AQUITAINE FR
Employees: 218
Phone: 33549893000
The current stock price of ALECR.PA is 17600 EUR. The price decreased by -3.83% in the last trading session.
The exchange symbol of EUROFINS CEREP-REGR is ALECR and it is listed on the Euronext Paris - Matif exchange.
ALECR.PA stock is listed on the Euronext Paris - Matif exchange.
EUROFINS CEREP-REGR (ALECR.PA) has a market capitalization of 176.00M EUR. This makes ALECR.PA a Micro Cap stock.
EUROFINS CEREP-REGR (ALECR.PA) currently has 218 employees.
EUROFINS CEREP-REGR (ALECR.PA) has a support level at 16208 and a resistance level at 17714.3. Check the full technical report for a detailed analysis of ALECR.PA support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ALECR.PA does not pay a dividend.
The PE ratio for EUROFINS CEREP-REGR (ALECR.PA) is 24.28. This is based on the reported non-GAAP earnings per share of 725 and the current share price of 17600 EUR. Check the full fundamental report for a full analysis of the valuation metrics for ALECR.PA.
ChartMill assigns a technical rating of 4 / 10 to ALECR.PA. When comparing the yearly performance of all stocks, ALECR.PA is one of the better performing stocks in the market, outperforming 97.89% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to ALECR.PA. ALECR.PA has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
Over the last trailing twelve months ALECR.PA reported a non-GAAP Earnings per Share(EPS) of 725. The EPS decreased by -21.28% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 16.86% | ||
ROA | 9.29% | ||
ROE | 10.82% | ||
Debt/Equity | 0 |